We are live on ! Find out more
BSPM

Biostar Pharmaceuticals, Inc.
BSPM

Delisted

BSPM was delisted on the 18th of September, 2018.

Back to rankings

1 hedge funds and large institutions have $1K invested in Biostar Pharmaceuticals, Inc. in 2019 Q1 according to their latest regulatory filings, with 0 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding

Funds holding: 1 → 1 (0)

50% less capital invested

Capital invested by funds: $2K → $1K (-$1K)

Holders
1
Holders Change
–
Holders Change %
0%
% of All Funds
0.02%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
PAM
1
Panagora Asset Management
Massachusetts
$1K – – –

BSPM Hedge Fund Activity: Q1 2019 in Review

1 of the 4,620 institutional investors tracked by Wall St. Rank reported a position in Biostar Pharmaceuticals, Inc. (BSPM) for Q1 2019, worth a combined $1K — down 50% from $2K a quarter earlier.

Fund positioning in BSPM was balanced in Q1 2019: 0 funds opened new positions, 0 closed out, 0 added to existing stakes and 0 trimmed.

  • 1 institutional investor held Biostar Pharmaceuticals, Inc. (BSPM) as of Q1 2019, unchanged from Q4 2018.
  • Funds reported $1K of Biostar Pharmaceuticals, Inc. stock for Q1 2019, down 50% quarter-over-quarter.
  • 0 funds opened new Biostar Pharmaceuticals, Inc. positions in Q1 2019 and 0 closed out.

Based on aggregated 13F filings for Q1 2019.